TY - JOUR
T1 - Fetoscopic insufflation of heated-humidified carbon dioxide during simulated spina bifida repair is safe under controlled anesthesia in the fetal lamb
AU - Joyeux, Luc
AU - Basurto, David
AU - Bleeser, Tom
AU - Van der Veeken, Lennart
AU - Vergote, Simen
AU - Kunpalin, Yada
AU - Trigo, Lucas
AU - Corno, Enrico
AU - De Bie, Felix R.
AU - De Coppi, Paolo
AU - Ourselin, Sebastien
AU - Van Calenbergh, Frank
AU - Hooper, Stuart B.
AU - Rex, Steffen
AU - Deprest, Jan
N1 - Funding Information:
We are grateful to Dr. Wouter Merckx and Stijn Massart from the Zootechnical Institute of KU Leuven for preparing and caring for the pregnant ewes, and to Dr. S. De Vleeschauwer from the KU Leuven animal research center and Rosita Kinnart from the KU Leuven Center for Surgical Technologies for their precious help in anesthetizing and caring for the animals. We also thank the following KU Leuven colleagues for their technical support: Anna‐Maria Mazzer, Ozgur Can Kilinc, Imke Loret, Francisco Vitale and Francesca Russo. Finally, we thank Dr. David Nittner from the VIB CCB Histopathology Expertise Center of KU Leuven for all the support regarding protocols and slides scanning. Luc Joyeux and Yada Kunpalin are supported by an Innovative Engineering for Health award by the Wellcome Trust (WT101957) and the Engineering and Physical Sciences Research Council (EPSRC) (NS/A000027/1). Luc Joyeux and Simen Vergote are supported by a TBM‐FWO grant. David Basurto, Lucas Trigo, and Lennart Van der Veeken were funded with support of the Erasmus+Programme of the European Union (Framework Agreement number: 2013‐0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Felix R. De Bie is supported by the Belgian Fulbright commission, the Belgian American Education Foundation, the Sofina‐Boel Foundation and the Flanders Research Foundation (FWO: 1S31720N). Jan Deprest was a Clinical Researcher of the Flanders Research Foundation (FWO Vlaanderen; 1.8.012.07) and is currently supported by the Great Ormond Street Hospital Charity fund. Paolo De Coppi is supported by the National Institute for Health Research (NIHR‐RP‐2014‐04‐046) and the BRC NIHR GOSH. The HumiGard™ insufflation system was generously provided free of charge by Fisher‐Paykel Healthcare, Auckland, New Zealand.
Funding Information:
We are grateful to Dr. Wouter Merckx and Stijn Massart from the Zootechnical Institute of KU Leuven for preparing and caring for the pregnant ewes, and to Dr. S. De Vleeschauwer from the KU Leuven animal research center and Rosita Kinnart from the KU Leuven Center for Surgical Technologies for their precious help in anesthetizing and caring for the animals. We also thank the following KU Leuven colleagues for their technical support: Anna-Maria Mazzer, Ozgur Can Kilinc, Imke Loret, Francisco Vitale and Francesca Russo. Finally, we thank Dr. David Nittner from the VIB CCB Histopathology Expertise Center of KU Leuven for all the support regarding protocols and slides scanning. Luc Joyeux and Yada Kunpalin are supported by an Innovative Engineering for Health award by the Wellcome Trust (WT101957) and the Engineering and Physical Sciences Research Council (EPSRC) (NS/A000027/1). Luc Joyeux and Simen Vergote are supported by a TBM-FWO grant. David Basurto, Lucas Trigo, and Lennart Van der Veeken were funded with support of the Erasmus+Programme of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Felix R. De Bie is supported by the Belgian Fulbright commission, the Belgian American Education Foundation, the Sofina-Boel Foundation and the Flanders Research Foundation (FWO: 1S31720N). Jan Deprest was a Clinical Researcher of the Flanders Research Foundation (FWO Vlaanderen; 1.8.012.07) and is currently supported by the Great Ormond Street Hospital Charity fund. Paolo De Coppi is supported by the National Institute for Health Research (NIHR-RP-2014-04-046) and the BRC NIHR GOSH. The HumiGard? insufflation system was generously provided free of charge by Fisher-Paykel Healthcare, Auckland, New Zealand.
Publisher Copyright:
© 2022 John Wiley & Sons Ltd.
PY - 2022/2
Y1 - 2022/2
N2 - Objective: To assess the safety of Partial-Amniotic-Insufflation-of-heated-humidified-CO2 (hPACI) during fetoscopic spina bifida repair (fSB-repair). Method: A simulated fSB-repair through an exteriorized uterus under hPACI was performed in 100-day fetal lambs (term = 145 days) under a laboratory anesthesia protocol (n = 5; group 1) which is known to induce maternal-fetal acidosis and hypercapnia. Since these may not occur clinically, we applied a clinical anesthesia protocol (n = 5; group 2), keeping maternal parameters within physiological conditions, that is, controlled maternal arterial carbon dioxide (CO2) pressure (pCO2 = 30 mmHg), blood pressure (≥67 mmHg), and temperature (37.1–39.8°C). Our superiority study used fetal pH as the primary outcome. Results: Compared to group 1, controlled anesthesia normalized fetal pH (7.23 ± 0.02 vs. 7.36 ± 0.02, p < 0.001), pCO2 (70.0 ± 9.1 vs. 43.0 ± 1.0 mmHg, p = 0.011) and bicarbonate (27.8 ± 1.1 vs. 24.0 ± 0.9 mmol/L, p = 0.071) at baseline. It kept them within clinically acceptable limits (pH ≥ 7.23, pCO2 ≤ 70 mmHg, bicarbonate ≤ 30 mm/L) for ≥120 min of hPACI as opposed to ≤30 min in group one. Fetal pO2 and lactate were comparable between groups and generally within normal range. Fetal brain histology demonstrated fewer apoptotic cells and higher neuronal density in the prefrontal cortex in group two. There was no difference in fetal membrane inflammation, which was mild. Conclusion: Fetoscopic insufflation of heated-humidified CO2 during simulated fSB-repair through an exteriorized uterus can be done safely under controlled anesthesia.
AB - Objective: To assess the safety of Partial-Amniotic-Insufflation-of-heated-humidified-CO2 (hPACI) during fetoscopic spina bifida repair (fSB-repair). Method: A simulated fSB-repair through an exteriorized uterus under hPACI was performed in 100-day fetal lambs (term = 145 days) under a laboratory anesthesia protocol (n = 5; group 1) which is known to induce maternal-fetal acidosis and hypercapnia. Since these may not occur clinically, we applied a clinical anesthesia protocol (n = 5; group 2), keeping maternal parameters within physiological conditions, that is, controlled maternal arterial carbon dioxide (CO2) pressure (pCO2 = 30 mmHg), blood pressure (≥67 mmHg), and temperature (37.1–39.8°C). Our superiority study used fetal pH as the primary outcome. Results: Compared to group 1, controlled anesthesia normalized fetal pH (7.23 ± 0.02 vs. 7.36 ± 0.02, p < 0.001), pCO2 (70.0 ± 9.1 vs. 43.0 ± 1.0 mmHg, p = 0.011) and bicarbonate (27.8 ± 1.1 vs. 24.0 ± 0.9 mmol/L, p = 0.071) at baseline. It kept them within clinically acceptable limits (pH ≥ 7.23, pCO2 ≤ 70 mmHg, bicarbonate ≤ 30 mm/L) for ≥120 min of hPACI as opposed to ≤30 min in group one. Fetal pO2 and lactate were comparable between groups and generally within normal range. Fetal brain histology demonstrated fewer apoptotic cells and higher neuronal density in the prefrontal cortex in group two. There was no difference in fetal membrane inflammation, which was mild. Conclusion: Fetoscopic insufflation of heated-humidified CO2 during simulated fSB-repair through an exteriorized uterus can be done safely under controlled anesthesia.
UR - https://www.scopus.com/pages/publications/85122957806
U2 - 10.1002/pd.6093
DO - 10.1002/pd.6093
M3 - Article
C2 - 35032031
AN - SCOPUS:85122957806
SN - 0197-3851
VL - 42
SP - 180
EP - 191
JO - Prenatal Diagnosis
JF - Prenatal Diagnosis
IS - 2
ER -